Broker-Dealer AgreementBroker-Dealer Agreement • September 3rd, 2020 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus
This agreement (together with exhibits and schedules, the “Agreement”) is entered into by and between Global Cancer Technology, Inc. (“Client”), a Delaware Corporation, and Dalmore Group, LLC., a New York Limited Liability Company (“Dalmore”). Client and Dalmore agree to be bound by the terms of this Agreement, effective as of July 15, 2020 (the “Effective Date”):
AMENDMENT NO. 1 TO LICENSE AGREEMENT NO. 2017-03-0236 (THE “AGREEMENT”) BETWEEN GLOBAL CANCER TECHNOLOGY, INC. AND THE UNIVERSITY OF CALIFORNIA FOR CASE NOS. SD2013-199, SD2016-342, AND UPON AMENDMENT, SD2020-395License Agreement • September 3rd, 2020 • Global Cancer Technology, Inc. • Surgical & medical instruments & apparatus
This amendment (“Amendment #1”) is made by and between Global Cancer Technology, Inc. a Nevada corporation, having an address at 16776 Bernardo Center Dr., Suite 203, San Diego, CA 92128 (“LICENSEE”), and The Regents Of The University Of California, a California corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200 (“UNIVERSITY”), as represented by its San Diego campus having an address at University of California, San Diego, Office of Innovation and Commercialization, Mail Code 0910, 9500 Gilman Drive, La Jolla, California 92093-0910 (“UCSD”).
